Anti TNF-α treatment of a refractory polymyositis;Traitement d'une polymyosite réfractaire par anti TNF-α

Revue de Medecine Interne

Volumn 28, Issue 3, 2007, Pages 194-195

  Wendling, D ^a   Prati, C ^a   Ornetti, P ^a   Toussirot, E ^a   Streit, G ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Infliximab; Polymyositis; Treatment

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG INDICATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; POLYMYOSITIS; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DRUG RESISTANCE; FEMALE; HUMANS; POLYMYOSITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847421700     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.12.001     Document Type: Article

References (9)

1. Efthimiou P. Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications. Semin. Arthritis Rheum. 36 (2006) 168-172
2. Anandacoomarasamy A., Howe G., and Manolios N. Advanced refractory polymyositis responding to infliximab. Rheumatol. 44 (2005) 562-563
3. Hengstman G.J., van den Hoogen F.H., Barrera P., Netea M.G., Pieterse A., van de Putte L.B., et al. Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur. Neurol. 50 (2003) 10-15
4. Labioche I., Liozon E., Weschler B., Loustaud-Ratti V., Soria P., and Vidal E. Refractory polymyositis responding to infliximab: extended follow-up. Rheumatol. 43 (2004) 531-532
5. Marie I., Heliot P., Roussel F., Herve F., Muir J.F., and Levesque H. Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatol. 44 (2005) 1201-1202
6. Sprott H., Glatzel M., and Michel B.A. Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1. Rheumatol. 43 (2004) 524-526
7. Uthman I., and El-Sayad J. Refractory polymyositis responding to infliximab. Rheumatol. 43 (2004) 1198-1199
8. Efthimiou P., Schwartzman S., and Kagen L.J. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients. Ann. Rheum. Dis. 65 (2006) 1233-1236
9. Musial J., Undas A., and Celinska-Lowenhoff M. Polymyositis associated with infliximab treatment for rheumatoid arthritis. Rheumatol. 42 (2003) 1566-1568